Asparagine–tRNA ligase, mitochondrial

NARS2
Identifiers
AliasesNARS2, SLM5, asnRS, DFNB94, asparaginyl-tRNA synthetase 2, mitochondrial (putative), asparaginyl-tRNA synthetase 2, mitochondrial
External IDsOMIM: 612803; MGI: 2142075; GeneCards: NARS2
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.1.1.22↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001243251
NM_024678

NM_153591

RefSeq (protein)

NP_001230180
NP_078954

NP_705819

Location (UCSC)Chr 11: 78.44 – 78.57 MbChr 7: 96.6 – 96.71 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Asparagine–tRNA ligase, mitochondrial, also called asparaginyl-tRNA synthetase 2, is an enzyme that in humans is encoded by the NARS2 gene. Like its cytoplasmic relative, NARS1, this enzyme is an asparagine–tRNA ligase which functions to attach the amino acid asparagine to its corresponding transfer RNA (denoted tRNAAsn), whose product is part of RNA-to-protein translation.

Medical Significance

Pathogenic variants in the gene NARS2 are associated with mitochondrial dysfunction, called combined oxidative phosphorylation deficiency-24 (COXPD24). Symptoms vary significantly between people, but often start in infancy, and include nervous system issues such as seizures, hearing impairment, and low muscle tone (hypotonia). People with more severe symptoms may have brain abnormalities that are visible on imaging and consistent with Leigh syndrome. Inheritance seems to follow an autosomal recessive pattern. Other symptoms in those with pathogenic mutations have also been reported, including neonatal diabetes and isolated deafness.

See also